Status:
COMPLETED
Comparison of Post- and Pre-dilutional Hemodiafiltration in Hemodialysis Patients
Lead Sponsor:
Tungs' Taichung Metroharbour Hospital
Conditions:
Hemodiafiltration
Eligibility:
All Genders
20+ years
Brief Summary
Hemodiafiltration (HDF) is a choice of treatment modalities for patients with end-stage renal disease. Hemodiafiltration, combining diffusion and convection, may increase removal of large and middle m...
Detailed Description
1. Study design: randomly assigned, cross-over study. 2. Patient number: 60. 3. Inclusion criteria: stable patients end-stage renal disease who were older than 20 years and received thrice-weekly stan...
Eligibility Criteria
Inclusion
- stable patients end-stage renal disease who were older than 20 years and received thrice-weekly standard hemodialysis for more than 3 months were recruited.
Exclusion
- active systemic disease, liver cirrhosis, malignancy, receiving immunosuppressive treatment, dialysis with temporal non-tunneled catheter, inadequate dialysis dose (kt/V\<1.2).
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 7 2019
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT03288285
Start Date
September 1 2017
End Date
April 7 2019
Last Update
April 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tungs' Taichung Metroharbour Hospital
Taichung, Taiwan